TfR1 Palmitoylation-Based Applications for Industrial, Agricultural, and Health Industries

Publication ID: 24-11857532_0002_PTD

Published: October 28, 2025

Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “TfR1 Palmitoylation-Based Applications for Industrial, Agricultural, and Health Industries,” Published Technical Disclosure No. 24-11857532_0002_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857532_0002_PTD

This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,532.

Summary of the Inventive Concept

This inventive concept leverages the core technology of TfR1 palmitoylation to develop novel solutions for optimizing crop yields, reducing environmental pollution, detecting iron-related disorders in livestock, monitoring industrial processes, and enhancing athletic performance.

Background and Problem Solved

The original patent focused on treating Friedreich ataxia by increasing TfR1 palmitoylation. However, the limitations of this approach were confined to the medical field. The new inventive concept addresses the need for innovative applications of TfR1 palmitoylation in various industries, including agriculture, environmental protection, livestock health, industrial processes, and athletic performance.

Detailed Description of the Inventive Concept

The new claims describe systems and methods that utilize TfR1 palmitoylation to optimize crop yields, reduce environmental pollution, detect iron-related disorders in livestock, monitor industrial processes, and enhance athletic performance. For instance, the system for optimizing crop yields uses a TfR1 palmitoylation-based algorithm to predict optimal iron levels in soil, adjusting fertilizer application accordingly. Similarly, the method for reducing environmental pollution treats wastewater with a TfR1 palmitoylation-enhancing agent to increase iron sequestration.

Novelty and Inventive Step

The new claims introduce a non-obvious and novel application of TfR1 palmitoylation, extending its use beyond medical treatments to various industrial, agricultural, and health-related fields. The inventive step lies in recognizing the potential of TfR1 palmitoylation to address specific problems in these industries and developing innovative solutions that leverage this technology.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include using TfR1 palmitoylation in other industries, such as cosmetics, biotechnology, or energy production. Variations of the systems and methods described in the new claims could involve different types of sensors, algorithms, or agents that enhance TfR1 palmitoylation.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in various industries, including agriculture, environmental protection, livestock health, industrial processes, and athletic performance. The market for these applications is vast, with potential customers ranging from farmers and agricultural companies to environmental organizations, livestock breeders, industrial manufacturers, and sports teams.

Section 103 Obviousness Analysis (PHOSITA)

▼

Field of Art

Molecular biology, biochemistry, and medical research focusing on iron metabolism, protein modification, and therapeutic interventions for genetic disorders

Person of Ordinary Skill (PHOSITA) Profile

A researcher with advanced degree in biochemistry or molecular biology, familiar with protein modification techniques, iron metabolism pathways, and interdisciplinary applications of cellular signaling mechanisms

Obviousness Rationale

A PHOSITA would recognize that the fundamental mechanism of TfR1 palmitoylation disclosed in the source patent provides a versatile technological platform with broad applicability across multiple domains. The core scientific principle of modulating iron uptake and cellular metabolism through protein modification suggests predictable extensions to agricultural, environmental, and performance optimization contexts. The PTD represents a natural progression of applying the core TfR1 palmitoylation technology to solve related technical challenges in different fields.

Obvious Combinations & Variations

Source Patent Element

Method of treating Friedreich ataxia by increasing TfR1 palmitoylation

PTD Variation

Applying TfR1 palmitoylation techniques to optimize crop iron levels and fertilization

Obviousness Reasoning

Known techniques for manipulating cellular iron metabolism can be predictably extended to agricultural systems, representing a straightforward application of established biochemical principles

Source Patent Element

Measuring total cellular iron content in peripheral blood mononuclear cells

PTD Variation

Developing diagnostic tools for detecting iron-related disorders in livestock

Obviousness Reasoning

Diagnostic methodologies for measuring iron metabolism are transferable across biological systems, representing a predictable adaptation of existing measurement techniques

Source Patent Element

Using drugs that increase TfR1 palmitoylation as therapeutic agents

PTD Variation

Employing TfR1 palmitoylation-enhancing agents to improve athletic performance

Obviousness Reasoning

Performance optimization through metabolic intervention is a well-established scientific approach, making the extension to athletic performance a logical and obvious variation

Source Patent Element

Treating genetic disorders through targeted molecular interventions

PTD Variation

Developing environmental remediation techniques using iron sequestration mechanisms

Obviousness Reasoning

Molecular techniques for controlling iron metabolism represent a generalizable approach that can be applied across biological and environmental systems

Source Patent Element

Measuring and modulating cellular iron content

PTD Variation

Creating industrial process monitoring systems based on iron metabolism principles

Obviousness Reasoning

Sensor and control technologies that leverage fundamental biochemical mechanisms represent a predictable technological extension

35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857532, the present publication demonstrates that a person having ordinary skill in the art would find the disclosed variations in agricultural, environmental, diagnostic, and performance optimization applications to be obvious extensions of the fundamental TfR1 palmitoylation mechanism. The predictable application of established biochemical principles across multiple domains renders the claimed innovations obvious and therefore anticipates potential patent claims in these technological spaces.

Original Patent Information

Patent Number	US 11,857,532
Title	Treatment and prediction of therapeutic responses in patients suffering from Friedreich ataxia
Assignee(s)	INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE), The Assistance Publique—Hôpitaux de Paris (APHP), FONDATION IMAGINE